| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |